Rare sinus cancer study aims to clarify treatment outcomes
NCT ID NCT07652489
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows people with a rare and advanced cancer of the nasal cavity and sinuses called T4 sinonasal adenoid cystic carcinoma. All participants receive the standard treatment: surgery followed by radiation therapy. The goal is to measure how long people live without the cancer growing or spreading, and to track side effects and quality of life. The results will help doctors better counsel patients and design future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide clearer survival expectations and guide treatment decisions for people with this rare cancer.
- What could go wrong
- This is an observational study, not a test of a new treatment. It cannot prove that surgery plus radiotherapy works better than other approaches.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eye & ENT Hospital of Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200031, China
-
The First Affiliated Hospital of Air Force Medical University
NOT_YET_RECRUITINGXi’an, Shanxi, 710032, China
-
The First Affiliated Hospital of China Medical University
NOT_YET_RECRUITINGShenyang, Liaoning, 110001, China
-
The First Affiliated Hospital of Wenzhou Medical University
NOT_YET_RECRUITINGWenzhou, Zhejiang, 325000, China
-
The Second Affiliated Hospital of Harbin Medical University
NOT_YET_RECRUITINGHarbin, Heilongjiang, 150001, China
-
Third Xiangya Hospital, Central South University
NOT_YET_RECRUITINGChangsha, Hunan, 410013, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo shrink Hard-to-Treat salivary gland tumors?
- Can a targeted drug shrink rare salivary gland tumors?
- Experimental drug tazemetostat offered to patients with rare, aggressive tumors
- New drug cocktail targets genetic weakness in rare cancer
- Drug duo takes on rare head and neck tumors
- New pill-chemo combo takes on hard-to-treat cancers